The initial development of Human Recombinant Thrombin, Human Recombinant Fibrinogen and Human Recombinant Collagen type III has been successful.  All above products will enter into pre-clinical trials during spring and summer of 2007.

• Recombinant Human Thrombin
• Recombinant Human Fibrinogen
• Recombinant Human Collagen type III
• HumaSealant, HumaSealant-C